Amedisys IPO
Amedisys is a leading provider of home health, hospice, and personal care services across the United States. The company serves patients in their homes through a network of care centers and healthcare professionals. Investors previously valued the company for its position in the growing home healthcare market driven by an aging population.
What We Know
Amedisys was a publicly traded company on NASDAQ under the ticker 'AMED' until it was acquired by UnitedHealth Group's Optum division in 2024. The acquisition was valued at approximately $3.3 billion, representing a significant premium to the company's trading price. The acquisition was part of UnitedHealth's strategy to expand its home-based care capabilities and integrate healthcare services. Amedisys shareholders received cash for their shares when the deal closed, and the company is no longer publicly traded as it operates as part of Optum's healthcare services division.
Frequently Asked Questions
Has Amedisys had an IPO?
Amedisys was previously a public company but completed its IPO many years ago. The company was acquired by UnitedHealth Group's Optum division in 2024 and is no longer publicly traded.
When is the Amedisys IPO date?
Amedisys is not planning an IPO as it was acquired by UnitedHealth Group in 2024. The company was previously public but is now part of Optum's healthcare services operations.
How can I buy Amedisys stock?
You cannot buy Amedisys stock as the company was acquired by UnitedHealth Group in 2024 and is no longer publicly traded. Investors interested in similar exposure might consider UnitedHealth Group (UNH) or other home healthcare companies.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts